Skip to main content

Clifford Chance

Clifford Chance

News and awards

Clifford Chance advises on US$5 billion Hong Kong IPO of AB InBev's Asia business

  • en
  • zh
  • Language options

30 September 2019

Clifford Chance advises on US$5 billion Hong Kong IPO of AB InBev's Asia business

Hong Kong's largest IPO and world's second largest this year

Leading international law firm Clifford Chance has advised the joint sponsors JP Morgan and Morgan Stanley and the underwriters on the US$5 billion initial public offering (IPO) and listing on the Hong Kong Stock Exchange of Budweiser Brewing Company APAC Limited (Budweiser APAC), the largest and a fast growing beer company in Asia Pacific.

The IPO of Budweiser APAC, the Asian business of Anheuser-Busch InBev Group (AB-InBev), is the second biggest IPO globally this year, and the largest in Hong Kong so far.

Partners Virginia Lee and Jean Thio led on the deal and were supported by partner Amy Lo, senior associates Janet Tang and Gehuan Liu, associates Helen Huang, Eunice Leung, Jeff Wong and Emma Bao, and trainees Michelle Sum and Anson Wong.

Virginia said, "We are delighted to advise on one of the most significant cross-border listings in Hong Kong this year, which will help to unlock and power AB InBev's continued growth globally and in the Asia Pacific region."

Jean added, "This transaction is testament to the strength of our market-leading practice, built over many years on advising companies and banks on their largest and most complex listings."

In Hong Kong this year, Clifford Chance has advised on Hansoh Pharmaceutical's US$1 billion IPO, Shenwan Hongyuan Group's US$1.16 billion IPO, Maoyan Entertainment's US$250 million IPO and Weimob's US$153 million IPO.

高伟绅为百威英博亚洲业务50亿美元的香港首次公开发行提供法律服务

国际领先律师事务所高伟绅就百威亚太控股有限公司(“百威亚太”)在香港证券交易所50亿美元的首次公开发行和上市,为联席保荐人摩根大通和摩根士丹利以及承销商提供法律服务。本次发行是本年度香港最大的首次公开发行和全球第二大首次公开发行。百威亚太是亚太地区最大和且快速成长的啤酒公司。

本次交易由高伟绅合伙人李婉雯律师和张珮真律师领导,合伙人罗秀娴律师亦提供支持。其他项目团队成员包邓敏蔚刘戈欢黄海伦梁咏愉王启尧包宸、岑晓欣和黄炜杰。

合伙人李婉雯律师表示,“我们非常高兴能够为香港本年度最重要的跨境上市交易提供法律服务,本交易将助力百威英博在全球和亚太地区的持续发展。”

合伙人张珮真律师补充道,“多年来,高伟绅团队在代表企业和投资银行完成大型复杂上市项目上积累了丰富经验。本次交易正是高伟绅市场领先地位的有力佐证。”

今年以来,高伟绅已参与完成了数个香港上市项目,其中包括翰森制药10亿美元的香港首次公开发行申万宏源集团11.6亿美元的香港首次公开发行猫眼娱乐2.5亿美元的香港首次公开发行微盟1.53亿美元的香港首次公开发行。